Risk Factors for Lactic Acidosis in HIV‐Infected Patients Treated with Nucleoside Reverse‐Transcriptase Inhibitors: A Case‐Control Study
Open Access
- 15 May 2003
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 36 (10) , 1324-1328
- https://doi.org/10.1086/374601
Abstract
A case-control study was undertaken to determine risk factors for lactic acidosis in human immunodeficiancy virus-infected patients treated with nuclKeywords
This publication has 17 references indexed in Scilit:
- Metabolic acidosis in HIV-infected patients.Clinical Infectious Diseases, 2002
- Severe Nucleoside-Associated Lactic Acidosis in Human Immunodeficiency Virus–Infected Patients: Report of 12 Cases and Review of the LiteratureClinical Infectious Diseases, 2002
- Symptomatic Lactic Acidosis in Hospitalized Antiretroviral‐Treated Patients with Human Immunodeficiency Virus Infection: A Report of 12 CasesClinical Infectious Diseases, 2001
- Hyperlactatemia and Antiretroviral Therapy: The Swiss HIV Cohort StudyClinical Infectious Diseases, 2001
- Hyperlactatemia and Hepatic Abnormalities in 10 Human Immunodeficiency Virus-Infected Patients Receiving Nucleoside Analogue Combination RegimensClinical Infectious Diseases, 2000
- Lactic Acidosis Associated with Stavudine Administration: A Report of Five CasesClinical Infectious Diseases, 2000
- Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndromeCritical Care Medicine, 1997
- Massive Hepatic Steatosis and Lactic Acidosis in a Patient with AIDS Who Was Receiving ZidovudineClinical Infectious Diseases, 1995
- Hepatomegaly with severe steatosis in HIV-seropositive patientsAIDS, 1993
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976